Intensive Medicines Monitoring Programme

The MARC reviews information collected from the mediccil literature and through adverse reactions monitoring, particularly the Intensive Medicines Monitoring Programme. It also makes recommendations on any appropriate action that may be required. 

I More intensive surveillance is expensive and usually restricted to hospital inpatients. I Examples include the Boston CoUaboiative Dmg Surveillance Programme (http //www.bu.edu/bcdsp) and the Medicines Evaluation and Monitoring Group... 

---